Quotes 5-day view Delayed Nasdaq Stockholm
05/13/2022
05/16/2022
05/17/2022
05/18/2022
05/19/2022
Date
231.6(c)
234.2(c)
239.6(c)
235.6(c)
238.2
Last
173 307
133 079
141 340
152 024
440 833
Volume
+3.95%
+1.12%
+2.31%
-1.67%
+1.10%
Change
Estimated financial data (e) SEK USD
Sales 2022
3 136 M
313 M
313 M
Net income 2022
443 M
44,3 M
44,3 M
Net Debt 2022
1 703 M
170 M
170 M
P/E ratio 2022
72,1x
Yield 2022
0,45%
Sales 2023
3 656 M
365 M
365 M
Net income 2023
620 M
62,0 M
62,0 M
Net Debt 2023
1 060 M
106 M
106 M
P/E ratio 2023
51,4x
Yield 2023
0,56%
Capitalization
31 899 M
3 188 M
3 188 M
EV / Sales 2022
10,7x
EV / Sales 2023
9,02x
Nbr of Employees
1 172
Free-Float
54,4%
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for...
Ratings of Vitrolife AB (publ)
All news about VITROLIFE AB (PUBL)
News in other languages on VITROLIFE AB (PUBL)
Chart VITROLIFE AB (PUBL)
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends VITROLIFE AB (PUBL)
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
2
Last Close Price
235,60 SEK
Average target price
433,00 SEK
Spread / Average Target
83,8%
Please enable JavaScript in your browser's settings to use dynamic charts.